Responses
Clinical/translational cancer immunotherapy
Original research
Incomplete Freund’s adjuvant reduces arginase and enhances Th1 dominance, TLR signaling and CD40 ligand expression in the vaccine site microenvironment
Compose a Response to This Article
Other responses
No responses have been published for this article.